Product Information
DESOXIMETASONE 0.25% OINTMENT is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.3686 per GM under NDC 45802049614. Its NADAC has been published 577 times since Jul 15, 2015.
FDA first approved this application on Apr 20, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5 mg/g
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802049614
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
DESOXIMETASONEApproval Type
Generic (ANDA)
FDA Application
ANDA077770FDA Approved
4/20/2015
TE Code
AB
On Market Since
5/14/2015
Pharmacological Classes
Price Statistics
The NADAC for DESOXIMETASONE 0.25% OINTMENT has been published 577 times since Jul 15, 2015, and over the history we have for it it has declined 92.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3686 per GM |
|---|---|
| All-time high | $5.2828 (Aug 12, 2015) |
| All-time low | $0.3262 (Jun 17, 2026) |
| 52-week high | $0.5058 |
| 52-week low | $0.3262 |
| Median price | $0.7512 |
| Average price | $1.4992 |
| Largest weekly change | +81.5% (Feb 17, 2021) |
| Weeks tracked | 577 |
| Tracking since | Jul 15, 2015 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 46% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Padagis Israel Pharmaceuticals Ltd manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Desoximetasone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DESOXIMETASONE 0.25% OINTMENT?
The current National Average Drug Acquisition Cost (NADAC) for DESOXIMETASONE 0.25% OINTMENT, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.3686 per GM (NDC 45802049614), effective Sep 30, 2026.
How has the price of DESOXIMETASONE 0.25% OINTMENT changed over time?
Over the history we have for it, the NADAC for DESOXIMETASONE 0.25% OINTMENT has declined 92.6%. It has been tracked across 577 weekly CMS publications since Jul 15, 2015.
What are the highest and lowest recorded NADAC prices for DESOXIMETASONE 0.25% OINTMENT?
Since Jul 15, 2015, the NADAC for DESOXIMETASONE 0.25% OINTMENT has ranged from a low of $0.3262 (Jun 17, 2026) to a high of $5.2828 (Aug 12, 2015), with a median of $0.7512 per GM.
Are there cheaper alternatives to DESOXIMETASONE 0.25% OINTMENT?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DESOXIMETASONE 0.25% OINTMENT, is $0.2000 per GM — about 46% below DESOXIMETASONE 0.25% OINTMENT.
Who manufactures DESOXIMETASONE 0.25% OINTMENT?
DESOXIMETASONE 0.25% OINTMENT (NDC 45802049614) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.